Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
ME-3 produces glutathione, it increases glutathione uptake into cells, and it also recycles, or regenerates oxidized or used up glutathione back to its reduced or active state
Please read our policy carefully before making a purchase
All preclinical data is consistently positive across musculoskeletal, GI, and neurological outcomes
When deficient, the brain becomes "defenseless" , leading to exhaustion and subsequent deficiencies
Nenna A, Spadaccio C, Lusini M, Ulianich L, Chello M, Nappi F
